We examined the expression of several molecular markers of protein balance in response to skeletal muscle atrophy induced by spinal cord isolation (SI, i.e., a complete transection of the spinal cord at both a mid-thoracic and a high sacral level plus complete differentiation between the two transection sites). This treatment nearly eliminates neuromuscular activity (activation and loading) of the hindlimb muscles while maintaining neuromuscular connectivity. SI was associated with a reduced transcriptional activity (via pre-mRNA analyses) of myosin heavy chain (MHC) and actin. In addition, there was an increased gene expression of enzyme systems impacting protein degradation (calpain 1; plus enzymes associated with polyubquitination processes) that could further contribute to the protein deficits in the SI muscles via degradative pathways. IGF-I receptor and binding protein-5 (BP-5) mRNA expression was induced throughout the 15-day period of SI, while IGF-I mRNA was induced at 8 and 15 days. These responses occurred in the absence of an upregulation of translational regulatory proteins (p70-S6 kinase; 4EBP1) to compensate for the decreased protein translational capacity. These data collectively demonstrate that 1) the molecular changes accompanying SI-induced muscle atrophy are not necessarily the reverse of those occurring during muscle hypertrophy, and 2) the rapid and marked atrophy that defines this model of muscle inactivity is likely the result of multifactorial processes affecting transcription, translation and protein degradation.
INTRODUCTION
In a companion study we demonstrated that the model of spinal cord isolation (SI), which results in near complete inactivity of the hind limb muscles while maintaining an intact neuromuscular connectivity, induces rapid muscle atrophy and a parallel deficit in protein balance (25) . Also, we observed a significant reduction in total RNA (i.e., ribosomal RNA) concentration and content in the soleus muscle, as well as significant reductions in mRNAs encoding key contractile and structural proteins such as myosin heavy chain (MHC) and actin.
In the present study, we addressed five working hypotheses to gain a better understanding of the factors contributing to the deficits in protein homeostasis in the hind limb muscles of SI rats. 1) The reductions in MHC and actin mRNA are due to decreased transcriptional activity of specific MHC and actin genes.
2) The decreases in the translational capacity are linked to upstream alterations in growth factor expression, e.g., reductions in insulin-like growth factor I (IGF-1) expression, including expression of IGF-1 associated receptor and binding proteins.
3) The phosphorylation state, and hence functional activity of marker signaling molecules such as ERK 1-2 and proteins regulating the initiation steps of protein translation, e.g., p70-S6 kinase and eukaryotic binding protein factor, 4EBP1, are reduced in response to SI. 4) Gene expression of enzymes linked to protein degradation is upregulated in response to SI. 5) Myogenic regulatory factor gene expression, i.e., cyclin D1, MyoD, myogenin, and P21, associated with cell proliferation/differentiation processes are repressed relative to the normal control state in response to SI. In testing these hypotheses, we examined a variety of marker molecules at different time points during the atrophy process. Based on these analyses, we conclude that the atrophy process in response to SI is heavily impacted by a reduction in the transcriptional activity of genes encoding key sarcomeric proteins (actin and myosin) of the muscle. This response lowers the mRNA substrate available for translation and is not offset by significant increases in the functional activity of enzymes regulating protein translation processes. Furthermore, the protein deficits appear to be exacerbated by increased gene expression of enzymes postulated to be associated with a) disassembly of the cytoskeletal/myofibril framework, and b) ubiquitination of proteins targeting them for degradation by the proteasomal machinery. Collectively, these data suggest that the rapid and marked atrophy associated with the SI model is likely the result of multifactorial processes affecting gene transcription, and protein translation and degradation.
METHODS Experimental Design.
Approximately 70 young adult female rats weighing ~230 + 5 grams were assigned randomly to either a normal control (NC; N=35) or a SI (N=35) group. Animals in each experimental group subsequently were assigned randomly into subgroups and studied on the day of (t=0) and 2, 4, 8, and 15 days after SI surgery. The rats in the SI group were anesthetized using an intraperitoneal injection of ketamine hydrochloride (70 mg/kg body weight) and acepromazine maleate (5 mg/kg body weight), and were subjected to complete spinal cord transections at both a mid-thoracic and an upper sacral level plus bilateral deafferentation between the two transection sites as described previously (23, 40) . These procedures were approved by the IACUC committee at UCLA, and they conformed to the animal care procedures and standards recommended by the American Physiological Society.
Tissue Processing.
At each time point animals from the appropriate subgroups were weighed, anesthetized with sodium pentobarbital (100 mg/kg), and then decapitated. The soleus muscles (as well as other limb muscles not reported in this study) were removed, quickly dissected free of connective tissue, quick frozen on dry ice, and subsequently stored at -80 0 C until used for biochemical/molecular analyses. Analyses for all subgroups involved an N of 6 or 7 per time point as presented in the data profiles.
Total RNA Isolation and Reverse Transcription (RT).
Total RNA extraction and RT procedures were as described in the companion paper (25).
Pre-mRNA Analyses For Assessing Transcriptional Activity of Sarcomeric Genes.
Gene expression can be regulated at several levels in the cells, i.e., at the transcriptional, posttranscriptional/pretranslational, translational, and posttranslational levels. One may gain understanding as to the site of regulation by examining the level of expression of protein, mRNA, and pre-mRNA along with their relationship to one another. To assess transcriptional activity of endogenous genes, nuclear run-on assays have traditionally been the standard procedure. Because of difficulties in obtaining skeletal muscle nuclei, and perhaps the inconvenience of the run-on assay (using large amounts of radioisotopes), very few studies have reported nuclear run-on assay results on muscle specific gene transcription (22, 26) . As an alternative to the nuclear run-on assay, analysis of pre-mRNA expression can be used to assess a gene's transcriptional activity (19, 35, 37) . To our knowledge, this approach has not been applied previously to study MHC or actin gene transcription. In this study, we have explored this approach by investigating transcriptional regulation of the type I MHC and α-skeletal actin genes in the soleus muscle of SI rats.
Type I MHC and Actin mRNA and Pre-mRNA Analyses.
All the RNA samples used for these analyses were treated with DNase to remove any trace of genomic DNA contamination. DNase treatment was performed according to the supplier's recommendation (Promega). Following DNase treatment, the RNA samples were re-extracted with tri-reagent LS and the RNA pellet was suspended in nuclease-free water. RNA concentration was determined by UV absorption at 260 nm, and the samples were stored at -80 o C for subsequent analysis with the reverse transcription-polymerase chain reaction (RT-PCR).
Semi-quantitative RT-PCR was used to analyze the expression of type I MHC and α-skeletal actin gene expression at the pre-mRNA and mRNA levels in NC and 8 day-SI soleus RNA samples. One µg of total RNA was reverse transcribed using Superscript II reverse transcriptase according to the supplier's recommendations (Invitrogen, Carlsbad, California), but with substitution of oligo dT primers with a gene specific antisense primer (primer 2 for the βMHC and primer 6 for the actin, see Table 1 ). pmoles of each of primer 1 and 2 for MHC, or primer 5 and 6 for actin (Table 1) .
Annealing was set at 56°C, and amplification was carried out for 24 cycles, using a 1-min extension period for each cycle, which resulted in a 546 bp PCR product for type I MHC and a 214 bp for α-skeletal actin. PCR to amplify type I MHC pre-mRNA or actin premRNA was similar to the above except that the cDNA dilutions were only 5-fold. The primers used were primer 3 and 4 for MHC and primer 7 and 8 for actin, and the number of cycles was raised to 30. This resulted in a 186 bp product for MHC and 210 bp for actin. Primer 3 is derived from the last intron of the β MHC gene (Haddad & Baldwin, unpublished data), while primer 7 is derived from the first intron of the actin gene. Thus, these primers can target only pre-mRNAs. The number of cycles and the PCR conditions for each target mRNA were optimized so that the amplified signal was still on the linear portion of a semilog plot of the yield expressed as a function of the number of cycles. As a check for genomic DNA contamination, PCR reactions were carried out using an equal amount of non-reverse transcribed RNA. These reactions turned out negative, thus validating the effectiveness of DNase treatment. PCR products were separated on a 2%
agarose gel by electrophoresis and they were stained with ethidium bromide. The signal quantification was conducted by laser scanning densitometry as reported previously (52).
Polymerase Chain Reaction (PCR).
A relative RT-PCR method, using 18S as an internal standard (Ambion, Austin, TX), was applied to study the expression of specific mRNAs for IGF-I, IGF-I receptor, IGF binding proteins (BP-4, and BP-5), myogenin, MyoD, cyclin D1, and p21. Also, additional analyses were made on calpain 1 and 2, and ubiquitination enzymes, the E2 14 kDa carrier protein, the E3α Ub ligase, and the newly discovered nuclear E3 ligase, atrogin-1 (10, 21) . The sequences for the various primers used for the specific target mRNAs are shown in Table 2 , and these primers were purchased from Life Technology, (Invitrogen, Carlsbad, California). In each PCR reaction, the 18S ribosomal RNA was coamplified with the target cDNA (mRNA) to serve as an internal standard and to allow correction for any differences in starting amounts of total RNA. PCR procedure and quantification methods were conducted as described previously (2, 24 
RESULTS
Transcriptional Activity of Type I MHC and Actin.
In the companion paper (25) we reported that mRNA levels for both actin and the type I MHC were markedly reduced in response to SI. Consistent with this response, we observed that during the first 7 days of SI there were 60-70% reductions in pre-mRNA levels of type I MHC and actin in the soleus muscles ( Fig. 1 ). This response correlated well with the reduction in the mRNA for these two genes that were assessed in the same RNA extracts ( Fig.1 C, F ). This significant reduction in transcriptional activity was not due to a general reduction of transcriptional activity of the SI muscle, because we have observed a significant increase in the pre-mRNA levels of the fast type IIb MHC gene (unpublished observation), which is consistent with the redirection of gene expression to a faster phenotype.
Muscle IGF-I System.
IGF-I has been associated with muscle growth via binding to its receptor that, in turn, initiates a cascade of intracellular events favoring a positive protein balance and cell growth. Based on the observed increase in IGF-I mRNA and protein in response to muscle overload (1), we expected a decrease in IGF-I mRNA in atrophying SI soleus.
Our results show that IGF-1 mRNA ( Fig. 2A ) levels relative to 18S were not different from control levels up to 4 days of SI, and they increased by 30-40% at day 8 and 15
despite the muscle experiencing severe atrophy. The mRNAs encoding the IGF-1 receptor and IGF-1 BP-5 were elevated during the experimental period (Fig. 2) . In contrast, the IGF BP-4 mRNA level did not change significantly throughout the experimental period (Fig. 2C ).
Extracellular Response Factors and Protein Translation Markers.
The "extracellular response kinases" (ERK1/2) are part of an intracellular signaling pathway leading to changes in gene transcription that is activated by a number of growth factors including IGF-I (20,51). At the sites detected by the antibodies used in this study, phosphorylation of ERK1 and ERK2 indicates that this pathway was activated. The phosphorylation of ERK1 was increased at day 8 of SI ( Fig. 3B ), whereas ERK2 was elevated at day 4 and 8 of SI (Fig. 3C ). These changes in the ERK phosphorylation levels occurred without altered total ERK expression as assessed by immunoblotting with an ERK antibody (Cell Signaling) (Fig. 3 ).
The phosphorylation of p70-S6K and of Eukaryotic 4E binding protein 1 (4EBP1) has been reported to be associated with an increase in translation of mRNAs encoded for specific components of the translation machinery and for proteins in general, respectively (17) . Increases in the phosphorylation of these proteins are known to occur in response to: a) increased muscle loading (8, 24) ; and/or b) IGF-I receptor binding (20, 38) . Analysis of these markers by western blotting demonstrate that in the SI samples, the phosphorylation level of p70-S6K tended to be higher at day 4 and 8, although this did not reach statistical significance (Fig. 4A ). The total amount of p70-S6K was not altered (Fig. 4B ). Levels of 4EBP1 expression and phosphorylation state were not different between normal control and SI soleus muscles ( Fig. 5A and B). To gain further insight on additional key marker proteins impacting protein translation, we examined the phosphorylation state of another regulatory protein in the initiation process, i.e., regulatory protein eIF2α. This protein can modulate the activity of eIF2B, the enzyme which controls one of the rate limiting steps in protein initiation (33, 48) . When eIF2α is phosphorylated, it inhibits eIF2B activity thereby reducing protein initiation. However, in SI, we observed a consistent, although not statistically significant, pattern of dephosphorylation of eIF2α, suggesting that this factor was not functioning in a mode to inhibit eIF2B activity (Fig. 6 ). Taken together, these findings indicate that there was no overall clear pattern in the soleus muscle of SI rats to suggest marked downregulation in either the functional properties (phosphorylation state) or protein levels of the protein translation system to explain the severe atrophy response.
Markers of Protein Degradation.
In view of the rapid loss in both muscle mass and protein in response to SI, it was of interest to ascertain if there were altered gene expression of enzyme systems associated with protein degradation. One enzyme system we focused on involved the calciumactivated calpains. The calpains have been proposed to play a role in dissociating certain proteins such as titin and α-actinin and releasing them from the myofibrillar complex (27). As presented in Figure 7 , there was a clear pattern of increased expression of calpain 1 mRNA that persisted up to 15 days of SI. Calpain 2 mRNA expression, on the other hand, did not change significantly throughout the SI period.
Since the ubiquitin-proteasome pathway has been proposed to be the primary pathway for degrading the bulk of proteins expressed in skeletal muscle including those disassociated from the sarcomere infrastructure (15,44), we examined three key enzymes in the enzymatic cascade of protein ubiquitination, i.e., E2 14kDa Ub Carrier Protein, the E3 α Ub Ligase, and atrogin-1, an E3 ubiquitin ligase of the SCF family (21), also called
Muscle Atrophy F-box (10) . Our data show no significant difference between normal control and SI mRNA levels for E2 14kDa Ub carrier protein (Fig. 8A ). However, there was an elevation in the ubiquitin E3α ligase mRNA levels in the SI soleus muscles throughout the experimental period (Fig. 8B ). E2 14kDa and E3α ligases are critical in degrading myofibrillar and muscle protein (32, 45) . Interestingly, although the functional properties of the atrogin-1 gene have not been elucidated (10, 21) , it is obvious that this gene was also highly responsive to SI (Fig. 8C) . In fact, the response of this gene was relatively greater and occurred at an earlier time point than that of E3 α ligase. These findings indicate that there are increases in mRNA expression of enzymes involved in critical steps of protein degradation. Also, the responses seem to be temporally consistent with the rapid stages of protein loss in the soleus muscle of SI animals. Furthermore, it is not clear whether these components of the protein degradation system have any preferential effect on MHC relative to actin in the soleus of SI rats in order to cause a larger deficit in MHC protein relative to actin as reported in the companion paper (29, 34, 36, 41) .
Gene Expression of Marker Proteins of the Cell Cycle.
Significant increases in the mRNA expression of molecular markers of the cell cycle such as cyclin D1, p21, as well as myogenic regulatory factors such as myogenin and MyoD were previously reported in skeletal muscle undergoing compensatory hypertrophy (4).
Cyclin D1 and p21 are associated with proliferation (entering the cell cycle) and differentiation (leaving the cell cycle) processes involving progenitor cells, e.g., satellite cells, respectively (43, 49) . Although myogenin and MyoD also are thought to be associated with the proliferation/differentiation processes of such progenitor cells (13, 49) , they also may serve as transcription factors in adult skeletal muscle fibers and may be involved in regulating phenotype properties (29,34,36,41). Thus, it was of considerable interest to ascertain how these markers would respond to SI, given that other models of atrophy such as hindlimb unloading, spaceflight and spinal cord transection have been associated with a loss of myonuclei (6) . We hypothesized that these markers would be downregulated if the function of satellite cell proliferation/differentiation were inhibited during the atrophy response associated with SI. Surprisingly, with the exception of cyclin D1, which decreased initially and then returned to control levels, the response of MyoD, myogenin, and p21 reflected marked upregulation in response to SI (Fig. 9 ).
DISCUSSION
The primary goal of this study was to identify the molecular markers of inactivityinduced atrophy of a slow muscle using the model of SI which near completely inactivate the muscle while maintaining intact nerve-muscle connections.. Several cellular (25) and molecular (present paper) responses were examined in the soleus muscle when subjected to SI intervention. The SI soleus experiences a severe protein imbalance that results in a rapid and significant loss in protein and muscle mass. In order to better understand the mechanism of protein loss in the SI muscle, we have assessed markers known to be Considerable evidence has accumulated to suggest that IGF-1 is an autocrine/paracrine growth factor that, alone, has skeletal muscle anabolic properties (1). Also, it has been implicated to be strategically involved in compensatory muscle growth in response to increased loading states imposed on the muscle (1, 3) . Therefore, we reasoned that the IGF-1 system might undergo downregulation and serve as a negative regulatory factor in response to muscle inactivity. The results reported herein negate this hypothesis and suggest that the IGF-I system components were either not changed or were upregulated in the SI muscles.
The role of IGF-I in muscle atrophy is not clear. IGF-I mRNA expression and protein decrease after denervation (11), but after hind limb unloading and in human muscle disuse, these levels have been reported to decrease (7), remain unchanged (14) or increase (39) . These apparently contradictory findings on the increased expression of IGF-I in atrophied muscle may be attributed to a counterregulatory response to conserve muscle mass. Although we have not determined the protein level of IGF-I in this study, generally there is a good agreement between the protein and mRNA for muscles undergoing atrophy (11) or hypertrophy (3). If IGF-I protein levels parallel the mRNA levels, our results suggest that IGF-I does not play a role in the atrophy process, at least as induced by SI. This is further supported by the fact that IGF-I over-expression did not prevent unloading-induced atrophy (14) . The IGF-I cellular action occurs via binding to its receptor that, in turn, can be modulated by various binding proteins. For example, IGFBP-5 is proposed to have a dual role: it either potentiates or inhibits the action of IGF-1, whereas IGFBP-4 is postulated to be a negative modulator (12, 16) . Our observation of an upregulation of BP-5 mRNA in the inactive soleus (Fig 2) is consistent with an upregulation in the muscles of hind limb unloaded rats (7). Collectively, these results suggest that muscle atrophy in response to inactivity occurs without an obligatory decrease in IGF-I mRNA expression and, thus, support the conclusion that the molecular responses involving the IGF-I system are not the reverse of what is observed in hypertrophying muscles.
Markers of Cell Signaling and Protein Initiation/Translation Processes.
In overload-induced hypertrophy, as well as in response to increased muscle activation associated with high-resistance exercise, several markers involved in intracellular signaling that can lead to increased transcriptional activity or increased protein translation and thought to greatly contribute to the anabolic response are activated by phosphorylation (2, 8, 9, 20, 24) . These signaling molecules include ERK1/2, p70-S6K, 4EBP1, and eIF2α. Since muscle atrophy in unloading models has been attributed partly to a decrease in protein synthesis (47), we anticipated that the activity of these factors would be downregulated in the atrophied SI muscles. Our findings (Figs. 4-6 ) would argue that these translation markers do not play a significant role in limiting the protein translation processes associated with a loss in protein in the soleus muscles of SI rats. On the other hand, it would appear that the significant decreases in ribosomal RNA observed in the companion paper (25), as well as the inability of the protein initiation apparatus to significantly augment its functional activity, act in combination with the reductions in sarcomeric gene mRNA substrate to impair the SI muscle from carrying out a sufficient level of protein translation to maintain the muscle in a state of normal protein homeostasis.
Protein Degradation Markers.
Protein degradation processes play a significant role in the turnover of muscle proteins and any alteration in the functional level of these pathways can significantly affect the balance of protein maintained in skeletal muscle. Evidence is rapidly accumulating that the ubiquitin-proteasome pathway is a key system in protein degradation, and that this may be the primary pathway in degrading the majority of muscle proteins, including the myofibril fraction, which accounts for ~50% of the total muscle protein pool. Evidence also suggests that individual myofibril proteins, e.g., myosin and actin, are not readily degraded by the Ub-proteasome when they are conjugated within the sarcomeric machinery (27,44-46). Thus, it has been proposed that other proteolytic systems must operate in synergy with the Ub-proteasome axis to bring about degradation of complex structures of the muscle such as the myofibrils. Therefore, we focused on examining a) enzyme systems thought to be involved in causing dissociation of myofibrils such as the calpains (27); and b) the pivotal steps in poly-ubiquitinating proteins prior to their subsequent degradation in the proteasome machinery, i.e., marker E2 and E3 ubiquitin enzymes. We found that gene expression for calpain 1 and enzymes representative of the E3 enzyme system were upregulated in the inactive muscles. The marked upregulation of the atrogin-1 gene is most intriguing in that this E3 enzyme contains specific sequences to suggest it may be preferentially located in the nucleus (10) . This raises the possibility that atrogin-1 may target the degradation of transcription factors, thereby negatively impacting the transcription of key sarcomeric genes as discussed above. If these patterns of response at the mRNA level translate to increased expression at the protein level, they could provide a mechanism for increase protein degradation. In combination with an inadequate capacity for protein translation as discussed above, the upregulation of these proteolytic factors could play an important role in the rapid protein loss that occurred in SI muscles.
Gene Expression of Markers of the Cell Cycle. (6) . In the context of this well-defined adaptive process during hypertrophy, we hypothesized that these proliferative/differentiation events would be either blunted or non-operative in the catabolic state of atrophying SI muscles. Surprisingly, with the exception of the cyclin D1 response pattern (which showed little change), the MyoD, myogenin, and p 21 upregulation responses were equally as robust as that seen under the conditions of functional overload (2, 4) . Assuming that the upregulation of MyoD, myogenin and P 21 has some functional role in the atrophic process, it is apparent that these proteins can mediate responses beyond simply modulating cell proliferation and differentiation. Interestingly, p21 is thought to have antiproliferative activity (53), and , thus, may be playing an inhibitory role on satellite cell proliferation. In addition, it is important to note the recent observation by Adams et al. (2) that overloaded-irradiated skeletal muscles, which are blunted in their ability to hypertrophy even when the stimulus is applied for several months, show an increased expression of the same markers noted above for SI muscles. In the atrophying condition, the muscles lose myonuclei via apoptosis (5,42), whereas in the "overloaded-irradiated condition" the hypertrophy process is blunted by irradiation by causing defects in the DNA structure and its ability to repair.
A limitation of our approach is that the markers were analyzed at the whole muscle level.
Based on the heterogeneous nature of skeletal muscles, this approach cannot be used to identify which components of the muscle were responsible for the expression of the myogenic/cell cycle markers. The fact that the atrophied muscles did not respond directly opposite to that observed in hypertrophied muscles is intriguing. However, these findings highlight the importance to better define the response in terms of which cell types Gb: Genbank accession number. Sequences are from the 5' to the 3' direction.
Table 2
Nucleotide sequence of the primers used for the RT-PCR mRNA analyses:
IGFI-BP4 and Ub E3α primer set sequences are from a conserved mouse mRNA sequence based on comparisons with the human mRNA sequence. Fwd: forward primer; Rev: reverse primer. Sequence listed is from the 5' to the 3' direction.
FIGURE LEGENDS. Phosphorylation of p70-S6K in control and SI muscles.
A: Western blots of representative samples for control (C) and SI groups. Also shown is a representative plantaris control and 3-day-overloaded (OL) sample from a different study to compare the intensity of the antibody reaction. The upper blot image is the result of a reaction using a phospho-specific antibody recognizing only the active p70-S6K form.
The lower blot image is the result of a reaction using a p70-S6K antibody that reacts with the p70-S6K protein regardless of its phosphorylation state. Both antibodies were purchased from Cell Signaling (Beverly, MA). B: Response for phospho-P70-S6K. C:
Response for total P70-S6K.
Each bar represents the average of n=6 or 7/group at each time point. *: p<0.05 vs. NC.
AU: arbitrary units 
Figure 6
Bar graph representing the mean values (+SE) of the phospho-eIF2α for NC and SI muscles at the indicated time points and as determined by western blotting analysis using a phospho-specific e-IF2α antibody. There were no significant differences between NC and SI at any time point. N=6-7/group. Also shown are representative immunoblots for control (C) and SI muscle samples at 2, 4, and 8 days. 
